TNFbeta+250 polymorphism and hyperdynamic state in cardiac surgery with extracorporeal circulation

Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1071-4. doi: 10.1510/icvts.2008.177501. Epub 2008 Sep 19.

Abstract

We have investigated genetic and clinical factors associated with hyperdynamic state (HS) after heart surgery with extracorporeal circulation (ECC). We performed a prospective cohort study of consecutive patients who underwent elective heart surgery with ECC. HS was defined as hyperthermia (>38 degrees C), cardiac index (CI) >3.5 l/min/m(2) and systemic vascular resistance index (SVRI) <1600 dynes x s/cm(5) x m(2). The study included demographic variables, gene polymorphisms A/G of tumor necrosis factor-beta (TNFbeta+250), G/A-1082 of interleukin-10 (IL-10), polymorphism of interleukin-1 receptor antagonist (IL-1ra), comorbidity, type of surgery, serum levels of interleukin-6 (IL-6), and postoperative course. We used Pearson chi(2) or Fisher exact test, and Student t-test for univariate analysis, with forward stepwise logistic regression for multivariate adjustment. Eighty patients were studied, of whom 22 (27.5%) developed HS. The presence of allele G of TNFbeta+250 polymorphism was associated with an increased incidence of HS (68% vs. 37%; P=0.011). In the multivariate analysis, a longer duration of ECC, and the presence of the G allele, were associated with the development of HS. The G allele of TNFbeta+250 polymorphism, and prolonged extracorporeal circuit times, may favor the development of a hyperdynamic state after heart surgery with ECC.

MeSH terms

  • Aged
  • Cardiac Surgical Procedures / adverse effects*
  • Cardiovascular Diseases / genetics*
  • Cardiovascular Diseases / physiopathology
  • Extracorporeal Circulation / adverse effects*
  • Female
  • Fever / genetics
  • Fever / physiopathology
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Hemodynamics / genetics*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / genetics
  • Interleukin-10 / genetics
  • Logistic Models
  • Lymphotoxin-alpha / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Vascular Resistance / genetics

Substances

  • IL10 protein, human
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Lymphotoxin-alpha
  • Interleukin-10